HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Low dose ketamine

TERMINATED · PHASE3 · Cancer, Mucositis

Unknown stopping reason

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.